Home > Resources > Company Profiles > Celera Corporation

Celera Corporation (CRA)

EMAIL
PRINT
SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Kathy P. Ordonez , Director/CEO
Industry: Technology
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Kathy P. Ordonez, Director/CEO

1401 Harbor Bay Parkway

Alameda, CA 94502

US Map it

Phone: (510) 749-4200

Fax:

www.celera.com



Overview

The Company is in the diagnostics business and delivers disease management through a clinical laboratory testing service business, a products business and a segment which includes other activities under corporate management.

News From Around the Web
News
powered by inform

Employees

Number of Employees: 554
Revenue per Employee: $263,328

Top Executives

Michael A. Zoccoli, General Manager, Divisional
Ugo D. DeBlasi, Vice President/Controller
Paul D. Arata, Vice President, Divisional

Dr. Stacey R. Sias, Other Executive Officer
Dr. Victor K. Lee, Other Executive Officer/Secretary
Tony L. White, CEO/Chairman of the Board/President/Director

Sandeep Nayyar, Controller/Vice President, Divisional
Mark P. Stevenson, Senior VP/President, Divisional/COO, Divisional
Barbara J. Kerr, Divisional Vice President

William B. Sawch, Senior VP/General Counsel
Joel R. Jung, CFO
Dennis L. Winger, CFO/Senior VP

Dr. Thomas J. White, Chief Scientific Officer

Board of Directors

Peter Barton Hutt, Director
Dr.Arnold J. Levine, Ph.D., Director
William G. Green, Director/Chairman of the Board

William H. Longfield, Director
Theodore M. Martin, Director
Orin R. Smith, Director

Dr. Victor K. Lee, Other Executive Officer/Secretary
Tony L. White, CEO/Chairman of the Board/President/Director
Jean-Luc Belingard, Director

Carolyn W. Slayman, Director
Elaine R. Mardis, Director Nominee
Dr. Bennett M. Shapiro, M.D., Director

Richard H. Ayers, Director

Financials

Quarterly
Annual

Income Statement 09/2008 05/2008 01/2008 11/2007
Sales 10.88 Mil. 11.61 Mil. 13.4 Mil. 1.65 Mil.
Gross Operating Profit 31.85 Mil. 27.84 Mil. 26.9 Mil. 14.49 Mil.
Operating Income before D & A (EBITDA) -5.36 Mil. -7.56 Mil. -3.8 Mil. -4.3 Mil.
Total Income Before Interest Expenses (EBIT) -6.51 Mil. -9.96 Mil. 500 K. 1.05 Mil.
Total Net Income -97.68 Mil. -7.36 Mil. 300 K. 665 K.
Basic EPS, Total -1.23 -0.09 0 0.01
Diluted EPS, Total -1.23 -0.09 0 0.01

BALANCE STATEMENT 09/2008 05/2008 01/2008 11/2007
Cash and Equivalents 47.32 Mil. 61.64 Mil. NA 187.26 Mil.
Total Assets 416.65 Mil. 415.1 Mil. NA 606.12 Mil.
Total Liabilities 30.44 Mil. 31.68 Mil. NA 16.43 Mil.
Total Capitalization 625.75 Mil. 749.98 Mil. NA 762.94 Mil.

Cash Flow 09/2008 05/2008 01/2008 11/2007
Net Cash From Continuing Operations -7.32 Mil. -37 K. NA -14.33 Mil.
Net Cash From Investing Activities 23.99 Mil. 36.08 Mil. NA 170.23 Mil.
Net Cash From Financing Activities -2.71 Mil. -4.44 Mil. NA 1.33 Mil.
Net Change in Cash & Cash Equivalents 13.96 Mil. 31.6 Mil. NA 157.22 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales 33.75 Mil. 10.71 Mil. 6.52 Mil. -2.94 Mil.
Gross Operating Profit 104.91 Mil. 32.66 Mil. 39.68 Mil. 33.98 Mil.
Operating Income before D & A (EBITDA) -17.58 Mil. -48.69 Mil. -90.76 Mil. -95.76 Mil.
Total Income Before Interest Expenses (EBIT) -14.94 Mil. -35.24 Mil. -102.11 Mil. -123.88 Mil.
Total Net Income -104.06 Mil. -19.76 Mil. -62.71 Mil. -77.12 Mil.
Basic EPS, Total -1.31 -0.25 -0.83 -1.15
Diluted EPS, Total -1.31 -0.25 -0.83 -1.15

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 47.32 Mil. 30.04 Mil. 60.27 Mil. 23.16 Mil.
Total Assets 416.65 Mil. 606.94 Mil. 620.35 Mil. 677.14 Mil.
Total Liabilities 30.44 Mil. 37.83 Mil. 41.43 Mil. 41.25 Mil.
Total Capitalization 625.75 Mil. 725.9 Mil. 726.43 Mil. 821.09 Mil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations -7.32 Mil. -24.87 Mil. -100.2 Mil. -87.56 Mil.
Net Cash From Investing Activities 23.99 Mil. -22.12 Mil. 139.41 Mil. 55.75 Mil.
Net Cash From Financing Activities -2.71 Mil. 16.76 Mil. -2.11 Mil. 3.43 Mil.
Net Change in Cash & Cash Equivalents 13.96 Mil. -30.23 Mil. 37.1 Mil. -28.38 Mil.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
Bruker Corporation
1.15 Bil.
Dionex Corporation
1.29 Bil.
Rofin-Sinar Technologies Inc
1.1 Bil.
ION Geophysical Corporation
1.01 Bil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented